TuHURA Biosciences, Inc.
HURA
$2.42
$0.020.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 32.78% | 67.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 24.73% | 12.61% | |||
| Operating Income | -24.73% | -12.61% | |||
| Income Before Tax | 4.80% | 25.42% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 4.80% | 25.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.80% | 25.42% | |||
| EBIT | -24.73% | -12.61% | |||
| EBITDA | -24.79% | -12.51% | |||
| EPS Basic | 8.99% | 34.42% | |||
| Normalized Basic EPS | -24.25% | -6.08% | |||
| EPS Diluted | 8.99% | 34.42% | |||
| Normalized Diluted EPS | -24.25% | -6.08% | |||
| Average Basic Shares Outstanding | 4.61% | 13.72% | |||
| Average Diluted Shares Outstanding | 4.61% | 13.72% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -0.05% | -0.34% | |||